UTHSC In the Media


Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children’s and UT Health Science Center

In the Media Icon

Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.


Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children’s and UT Health Science Center

In the Media Icon

Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.


Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children’s and UT Health Science Center

In the Media Icon

Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.


Memphis City Council requests meeting to reconsider building new Regional One facility

In the Media Icon

Memphis City Council members voted Tuesday to ask the Shelby County mayor and commission to hold a meeting to reconsider building the new Regional One Health facility.


RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures

In the Media Icon

RevBio, Inc., announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).


RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures

In the Media Icon

This Grant will Advance the Company’s Preclinical Research to Demonstrate an Improvement to the Current Standard of Care for Treating Vertebral Compression Fractures


RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures

In the Media Icon

This Grant will Advance the Company’s Preclinical Research to Demonstrate an Improvement to the Current Standard of Care for Treating Vertebral Compression Fractures


Key Healthcare Construction Projects in the United States

In the Media Icon

Across the United States, healthcare systems are investing billions of dollars in new hospitals, specialty centers, and campus redevelopments that will shape the future of patient care for decades to come.